Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders.
Adult
Birth Rate
Drug Resistance
Female
Fertility Agents, Female
/ therapeutic use
Fertilization in Vitro
/ methods
Humans
Infant, Newborn
Infertility, Female
/ diagnosis
Male
Maternal Age
Menstrual Cycle
/ physiology
Ovarian Function Tests
/ classification
Ovulation Induction
/ adverse effects
Patient Selection
Pregnancy
Pregnancy Rate
Research Design
/ standards
Retrospective Studies
Treatment Failure
Bologna criteria
IVF
Modified natural cycle
Oocytes
Poor responders
Journal
Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
17
02
2019
revised:
09
04
2019
accepted:
10
05
2019
pubmed:
7
8
2019
medline:
21
8
2020
entrez:
7
8
2019
Statut:
ppublish
Résumé
Do ongoing pregnancy rates (OPR) differ between modified natural cycle IVF (MNC-IVF) and conventional high-dose ovarian stimulation (HDOS) in advanced-age Bologna poor responders? This was a retrospective cohort study including patients with poor ovarian response (POR) attending a tertiary referral university hospital from 1 January 2011 to 1 March 2017. All women who fulfilled the Bologna criteria for POR and aged ≥40 years who underwent their first intracytoplasmic sperm injection (ICSI) cycle in the study centre were included. In total, 476 advanced-age Bologna poor responder patients were included in the study: 189 in the MNC-IVF group and 287 in the HDOS group. OPR per patient were significantly lower in the MNC-IVF group (5/189, 2.6%) compared with the HDOS group (29/287, 10.1%) (P = 0.002). However, after adjustment for relevant confounders (number of oocytes and presence of at least one top-quality embryo), the multivariate logistic regression analysis showed that the type of treatment strategy (HDOS versus MNC-IVF) was not significantly associated with OPR (odds ratio 2.56, 95% confidence interval 0.9-7.6). In advanced-age Bologna poor responders, MNC-IVF, which is a more patient-friendly approach, could be a reasonable alternative in this difficult-to-treat group of women.
Identifiants
pubmed: 31383604
pii: S1472-6483(19)30547-4
doi: 10.1016/j.rbmo.2019.05.009
pii:
doi:
Substances chimiques
Fertility Agents, Female
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
698-703Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.